Literature DB >> 8220136

Candida tropicalis infections in children with leukemia.

P M Flynn1, N M Marina, G K Rivera, W T Hughes.   

Abstract

The Candida species account for approximately three-fourths of fungal infections in patients with cancer. Although Candida albicans is the most frequent cause, C. tropicalis is increasingly implicated as an important pathogen. Over a 12 year period 19 children treated for leukemia at our institution developed C. tropicalis infections. We describe their clinical presentation, extent of fungal infection, treatment, and outcome. Fungemia without meningitis in 11 children was treated successfully, whereas C. tropicalis meningitis in 7 children was uniformly fatal. An additional patient had unsuspected, widespread infection detected at autopsy. Multiple sites, including the cerebrospinal fluid yielded C. tropicalis. Previously reported risk factors including neutropenia, broad-spectrum antibiotic usage, corticosteroid therapy, and total parenteral nutrition were observed in our cases. A high index of suspicion and the early use of aggressive antifungal therapy are critical to the successful management of C. tropicalis infections in children with leukemia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8220136     DOI: 10.3109/10428199309148562

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  7 in total

1.  Safety, tolerance, and pharmacokinetics of amphotericin B lipid complex in children with hepatosplenic candidiasis.

Authors:  T J Walsh; P Whitcomb; S Piscitelli; W D Figg; S Hill; S J Chanock; P Jarosinski; R Gupta; P A Pizzo
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

2.  Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescents.

Authors:  Thomas J Walsh; Peter C Adamson; Nita L Seibel; Patricia M Flynn; Michael N Neely; Cindy Schwartz; Aziza Shad; Sheldon L Kaplan; Maureen M Roden; Julie A Stone; Alisha Miller; Susan K Bradshaw; Susan X Li; Carole A Sable; Nicholas A Kartsonis
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

3.  Neonatal candidiasis: analysis of epidemiology, drug susceptibility, and molecular typing of causative isolates.

Authors:  E Roilides; E Farmaki; J Evdoridou; J Dotis; E Hatziioannidis; M Tsivitanidou; E Bibashi; I Filioti; D Sofianou; C Gil-Lamaignere; F-M Mueller; G Kremenopoulos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-10       Impact factor: 3.267

4.  Candida tropicalis in a neonatal intensive care unit: epidemiologic and molecular analysis of an outbreak of infection with an uncommon neonatal pathogen.

Authors:  Emmanuel Roilides; Evangelia Farmaki; Joanna Evdoridou; Andrea Francesconi; Miki Kasai; Joanna Filioti; Maria Tsivitanidou; Danai Sofianou; George Kremenopoulos; Thomas J Walsh
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

5.  Multimodality imaging of Candida tropicalis myositis.

Authors:  Daniel M Schwartz; Elaine R Morgan
Journal:  Pediatr Radiol       Date:  2007-12-20

6.  Treatment of fungal myositis with intra-lesional and intravenous itraconazole: a case report.

Authors:  Xiao-Ji Lin; Rong-Xin Yao; Mu-Qing He; Bao-Ling Zhu; Wen-Jian Guo
Journal:  J Med Case Rep       Date:  2013-05-19

7.  Mucosal damage and neutropenia are required for Candida albicans dissemination.

Authors:  Andrew Y Koh; Julia R Köhler; Kathleen T Coggshall; Nico Van Rooijen; Gerald B Pier
Journal:  PLoS Pathog       Date:  2008-02-08       Impact factor: 6.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.